Skip to main content
. 2015 Feb 9;22(2):67–74. doi: 10.3727/096504014X14024160459168

Figure 5.

Figure 5

Evaluation of the quality of life (symptoms) between the DC-CIK group and chemotherapy group based on the QLQ-C30 questionnaire. *Statistical significance (p < 0.05). CT, chemotherapy.